Correlation Between Ascendis Pharma and Atreca

Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and Atreca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and Atreca into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ascendis Pharma AS and Atreca Inc, you can compare the effects of market volatilities on Ascendis Pharma and Atreca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of Atreca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and Atreca.

Diversification Opportunities for Ascendis Pharma and Atreca

-0.3

Correlation Coefficient

Ascendis Pharma  Atreca

Very good diversification

The 3 months correlation between Ascendis and Atreca is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and Atreca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atreca Inc and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with Atreca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atreca Inc has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and Atreca go up and down completely randomly.

Pair Corralation between Ascendis Pharma and Atreca

If you would invest  12,866  in Ascendis Pharma AS on October 21, 2024 and sell it today you would lose (53.00) from holding Ascendis Pharma AS or give up 0.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.61%
Values	Daily Returns

Ascendis Pharma AS  vs.  Atreca Inc

Ascendis Pharma AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ascendis Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Ascendis Pharma is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Atreca Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Atreca Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Atreca is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Ascendis Pharma and Atreca

The main advantage of trading using opposite Ascendis Pharma and Atreca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, Atreca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atreca will offset losses from the drop in Atreca's long position.

The idea behind Ascendis Pharma AS and Atreca Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.